These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23042535)

  • 1. Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and β cell regeneration in a T1D model.
    Nti BK; Markman JL; Bertera S; Styche AJ; Lakomy RJ; Subbotin VM; Trucco M; Zorina TD
    Cell Mol Immunol; 2012 Nov; 9(6):455-63. PubMed ID: 23042535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient Depletion of Foxp3
    Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
    Front Immunol; 2021; 12():720133. PubMed ID: 34447385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells control insulitis and increase Treg cells to confer protection against STZ-induced type 1 diabetes in mice.
    Carlos D; Yaochite JN; Rocha FA; Toso VD; Malmegrim KC; Ramos SG; Jamur MC; Oliver C; Camara NO; Andrade MV; Cunha FQ; Silva JS
    Eur J Immunol; 2015 Oct; 45(10):2873-85. PubMed ID: 26234742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity.
    Kaminitz A; Mizrahi K; Askenasy N
    Autoimmunity; 2014 Mar; 47(2):105-12. PubMed ID: 24328490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes.
    Diaz-de-Durana Y; Lau J; Knee D; Filippi C; Londei M; McNamara P; Nasoff M; DiDonato M; Glynne R; Herman AE
    PLoS One; 2013; 8(10):e78483. PubMed ID: 24205242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras inhibition attenuates pancreatic cell death and experimental type 1 diabetes: possible role of regulatory T cells.
    Aizman E; Mor A; George J; Kloog Y
    Eur J Pharmacol; 2010 Sep; 643(1):139-44. PubMed ID: 20599916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.
    Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A
    Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes.
    Ferraro A; Socci C; Stabilini A; Valle A; Monti P; Piemonti L; Nano R; Olek S; Maffi P; Scavini M; Secchi A; Staudacher C; Bonifacio E; Battaglia M
    Diabetes; 2011 Nov; 60(11):2903-13. PubMed ID: 21896932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Mellanby RJ; Thomas D; Phillips JM; Cooke A
    Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of TNF-α in mice with type 1- and 2- diabetes.
    Koulmanda M; Bhasin M; Awdeh Z; Qipo A; Fan Z; Hanidziar D; Putheti P; Shi H; Csizuadia E; Libermann TA; Strom TB
    PLoS One; 2012; 7(5):e33254. PubMed ID: 22606220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes.
    Huang SH; Kuo SL; Chen SJ; Lin JR; Chen YW; Hong ZJ; Sytwu HK; Lin GJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
    Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
    PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of Autoimmune Diabetes of NOD Mice by Immunomodulating Probiotics.
    Kim TK; Lee JC; Im SH; Lee MS
    Front Immunol; 2020; 11():1832. PubMed ID: 33013834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.
    Aboumrad E; Madec AM; Thivolet C
    Clin Exp Immunol; 2007 Jun; 148(3):432-9. PubMed ID: 17374136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells.
    Li Z; Shi X; Liu J; Shao F; Huang G; Zhou Z; Zheng P
    FASEB J; 2019 Jul; 33(7):8241-8248. PubMed ID: 30916998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
    Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
    Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice.
    Xue M; Dervish S; Harrison LC; Fulcher G; Jackson CJ
    J Biol Chem; 2012 May; 287(20):16356-64. PubMed ID: 22447930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.